COVID-19 Pandemic–Related Outcomes in High-Risk Gastrointestinal Cancers—Beyond the Numbers
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée à la COVID-19
Janczewski and colleagues contribute to the literature with a comprehensive comparison of pandemic-related differences, including incidence, stage at diagnosis, 1-year survival, and 30-day and 90-day operative mortality, in patients with high-risk gastrointestinal (HRGI) cancers. This retrospective cohort analysis was performed using the National Cancer Database (NCDB) with data comparison extending from the prepandemic years (including 2018 and 2019) to the height of the COVID-19 pandemic through 2020. To our knowledge, this report is the largest retrospective study examining pandemic-related outcomes data for patients with HRGI cancers. According to their findings, the observed outcomes data in 2020 paralleled those of the prepandemic years studied.
JAMA Network Open 2024